

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | central nervous system myelination (GO:0022010) | 9.98828823 |
| 2 | axon ensheathment in central nervous system (GO:0032291) | 9.98828823 |
| 3 | pyrimidine nucleobase catabolic process (GO:0006208) | 7.41801077 |
| 4 | phosphorelay signal transduction system (GO:0000160) | 6.62035712 |
| 5 | behavioral response to nicotine (GO:0035095) | 6.23703548 |
| 6 | modulation by virus of host process (GO:0019054) | 6.10553110 |
| 7 | fatty acid elongation (GO:0030497) | 5.98870822 |
| 8 | negative regulation of execution phase of apoptosis (GO:1900118) | 5.97898053 |
| 9 | nucleobase catabolic process (GO:0046113) | 5.68267860 |
| 10 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 5.22923696 |
| 11 | detection of calcium ion (GO:0005513) | 5.17330765 |
| 12 | long-chain fatty acid biosynthetic process (GO:0042759) | 5.08837576 |
| 13 | ensheathment of neurons (GO:0007272) | 4.82552422 |
| 14 | axon ensheathment (GO:0008366) | 4.82552422 |
| 15 | myelination (GO:0042552) | 4.81517456 |
| 16 | negative regulation of catenin import into nucleus (GO:0035414) | 4.72125156 |
| 17 | modulation by symbiont of host cellular process (GO:0044068) | 4.71592989 |
| 18 | establishment of mitochondrion localization (GO:0051654) | 4.64520782 |
| 19 | negative regulation of amino acid transport (GO:0051956) | 4.61134865 |
| 20 | dendritic spine morphogenesis (GO:0060997) | 4.60923232 |
| 21 | amyloid precursor protein metabolic process (GO:0042982) | 4.58280356 |
| 22 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 4.41156084 |
| 23 | substrate-independent telencephalic tangential migration (GO:0021826) | 4.41156084 |
| 24 | arginine catabolic process (GO:0006527) | 4.39627151 |
| 25 | protein neddylation (GO:0045116) | 4.33707554 |
| 26 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 4.19180923 |
| 27 | regulation of glutamate secretion (GO:0014048) | 4.18795457 |
| 28 | retinal ganglion cell axon guidance (GO:0031290) | 4.18141423 |
| 29 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 4.16076335 |
| 30 | myelin maintenance (GO:0043217) | 4.15096552 |
| 31 | regulation of glycogen (starch) synthase activity (GO:2000465) | 4.11842717 |
| 32 | neuronal ion channel clustering (GO:0045161) | 4.07544612 |
| 33 | cell proliferation in forebrain (GO:0021846) | 4.07432067 |
| 34 | cellular response to virus (GO:0098586) | 3.97323507 |
| 35 | apical protein localization (GO:0045176) | 3.90961797 |
| 36 | negative regulation of neurotransmitter transport (GO:0051589) | 3.81799809 |
| 37 | cholesterol biosynthetic process (GO:0006695) | 3.81670954 |
| 38 | response to methylmercury (GO:0051597) | 3.81024841 |
| 39 | negative regulation of heart rate (GO:0010459) | 3.77634161 |
| 40 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.76926394 |
| 41 | nerve growth factor signaling pathway (GO:0038180) | 3.71951744 |
| 42 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.69779012 |
| 43 | limb bud formation (GO:0060174) | 3.68476297 |
| 44 | glutathione biosynthetic process (GO:0006750) | 3.67724178 |
| 45 | epithelial cilium movement (GO:0003351) | 3.65733469 |
| 46 | neuronal action potential (GO:0019228) | 3.62019664 |
| 47 | neural tube formation (GO:0001841) | 3.61417729 |
| 48 | sterol biosynthetic process (GO:0016126) | 3.59072560 |
| 49 | regulation of protein targeting to membrane (GO:0090313) | 3.55344830 |
| 50 | neurofilament cytoskeleton organization (GO:0060052) | 3.54956040 |
| 51 | amyloid precursor protein catabolic process (GO:0042987) | 3.51574905 |
| 52 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.51384887 |
| 53 | forebrain neuron differentiation (GO:0021879) | 3.48988567 |
| 54 | oligodendrocyte differentiation (GO:0048709) | 3.46937426 |
| 55 | axonal fasciculation (GO:0007413) | 3.44321438 |
| 56 | head development (GO:0060322) | 3.44070966 |
| 57 | synaptic transmission, cholinergic (GO:0007271) | 3.41046750 |
| 58 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 3.40464856 |
| 59 | regulation of collateral sprouting (GO:0048670) | 3.40218062 |
| 60 | spinal cord association neuron differentiation (GO:0021527) | 3.39962245 |
| 61 | negative regulation of amine transport (GO:0051953) | 3.39911362 |
| 62 | microtubule bundle formation (GO:0001578) | 3.39318753 |
| 63 | auditory behavior (GO:0031223) | 3.37965263 |
| 64 | parturition (GO:0007567) | 3.37672026 |
| 65 | glycerophospholipid catabolic process (GO:0046475) | 3.35574244 |
| 66 | asymmetric protein localization (GO:0008105) | 3.34559010 |
| 67 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.34018956 |
| 68 | photoreceptor cell differentiation (GO:0046530) | 3.33918964 |
| 69 | eye photoreceptor cell differentiation (GO:0001754) | 3.33918964 |
| 70 | isoprenoid biosynthetic process (GO:0008299) | 3.32129664 |
| 71 | cytidine deamination (GO:0009972) | 3.31260975 |
| 72 | cytidine metabolic process (GO:0046087) | 3.31260975 |
| 73 | cytidine catabolic process (GO:0006216) | 3.31260975 |
| 74 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.30927151 |
| 75 | negative regulation of glycogen biosynthetic process (GO:0045719) | 3.27972560 |
| 76 | protein localization to synapse (GO:0035418) | 3.26720906 |
| 77 | negative regulation of axon guidance (GO:1902668) | 3.26386806 |
| 78 | import into cell (GO:0098657) | 3.25232128 |
| 79 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.24721252 |
| 80 | pyrimidine-containing compound catabolic process (GO:0072529) | 3.19589032 |
| 81 | negative regulation of protein localization to cell surface (GO:2000009) | 3.18021630 |
| 82 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.17624196 |
| 83 | postsynaptic membrane organization (GO:0001941) | 3.17412341 |
| 84 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.17343027 |
| 85 | axonemal dynein complex assembly (GO:0070286) | 3.16696252 |
| 86 | transmission of nerve impulse (GO:0019226) | 3.16153134 |
| 87 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.14204016 |
| 88 | cellular response to monoamine stimulus (GO:0071868) | 3.13775590 |
| 89 | cellular response to catecholamine stimulus (GO:0071870) | 3.13775590 |
| 90 | positive regulation of protein targeting to membrane (GO:0090314) | 3.13353498 |
| 91 | synapse assembly (GO:0007416) | 3.10981857 |
| 92 | positive regulation of growth hormone secretion (GO:0060124) | 3.10720503 |
| 93 | venous blood vessel morphogenesis (GO:0048845) | 3.10147943 |
| 94 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 3.09007229 |
| 95 | neuron recognition (GO:0008038) | 3.08892880 |
| 96 | response to lipoprotein particle (GO:0055094) | 3.08276539 |
| 97 | activated T cell proliferation (GO:0050798) | 3.07849279 |
| 98 | peptide biosynthetic process (GO:0043043) | 3.07081071 |
| 99 | negative regulation of anoikis (GO:2000811) | 3.05850836 |
| 100 | response to monoamine (GO:0071867) | 3.05191718 |
| 101 | response to catecholamine (GO:0071869) | 3.05191718 |
| 102 | negative regulation of response to food (GO:0032096) | 3.04260677 |
| 103 | negative regulation of appetite (GO:0032099) | 3.04260677 |
| 104 | cellular response to gamma radiation (GO:0071480) | 3.04187017 |
| 105 | cilium movement (GO:0003341) | 3.03083744 |
| 106 | cellular response to prostaglandin stimulus (GO:0071379) | 3.02817041 |
| 107 | genetic imprinting (GO:0071514) | 3.01683459 |
| 108 | presynaptic membrane organization (GO:0097090) | 3.00883894 |
| 109 | protein polyglutamylation (GO:0018095) | 3.00301784 |
| 110 | protein targeting to Golgi (GO:0000042) | 2.99627198 |
| 111 | DNA deamination (GO:0045006) | 2.98109533 |
| 112 | interferon-gamma production (GO:0032609) | 2.97764750 |
| 113 | regulation of chromatin binding (GO:0035561) | 2.97408898 |
| 114 | axon extension (GO:0048675) | 2.95940286 |
| 115 | adipose tissue development (GO:0060612) | 2.95221969 |
| 116 | regulation of feeding behavior (GO:0060259) | 2.94857313 |
| 117 | L-amino acid import (GO:0043092) | 2.94013324 |
| 118 | sequestering of actin monomers (GO:0042989) | 2.93027851 |
| 119 | response to redox state (GO:0051775) | 2.89989885 |
| 120 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.88478445 |
| 121 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.88478445 |
| 122 | establishment of protein localization to Golgi (GO:0072600) | 2.86769224 |
| 123 | cellular copper ion homeostasis (GO:0006878) | 2.86692433 |
| 124 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.84098990 |
| 125 | arginine metabolic process (GO:0006525) | 2.84010802 |
| 126 | regulation of execution phase of apoptosis (GO:1900117) | 2.83829959 |
| 127 | vitamin A metabolic process (GO:0006776) | 2.82927274 |
| 128 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.82557464 |
| 129 | regulation of lipoprotein metabolic process (GO:0050746) | 2.82451694 |
| 130 | intraciliary transport (GO:0042073) | 2.80006217 |
| 131 | regulation of female receptivity (GO:0045924) | 2.79748765 |
| 132 | sensory perception of smell (GO:0007608) | 2.79249895 |
| 133 | regulation of synapse structural plasticity (GO:0051823) | 2.79184661 |
| 134 | positive regulation of mitochondrial fission (GO:0090141) | 2.78159374 |
| 135 | cellular biogenic amine catabolic process (GO:0042402) | 2.77999361 |
| 136 | amine catabolic process (GO:0009310) | 2.77999361 |
| 137 | mitochondrion transport along microtubule (GO:0047497) | 2.77451120 |
| 138 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.77451120 |
| 139 | mating behavior (GO:0007617) | 2.76435587 |
| 140 | regulation of cilium movement (GO:0003352) | 2.75769391 |
| 141 | olfactory bulb development (GO:0021772) | 2.75492899 |
| 142 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.75435404 |
| 143 | mechanosensory behavior (GO:0007638) | 2.74932202 |
| 144 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.74608583 |
| 145 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.74608583 |
| 146 | negative regulation of microtubule polymerization (GO:0031115) | 2.73846797 |
| 147 | substantia nigra development (GO:0021762) | 2.73531376 |
| 148 | axoneme assembly (GO:0035082) | 2.73010707 |
| 149 | regulation of microtubule-based movement (GO:0060632) | 2.72713549 |
| 150 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.71141028 |
| 151 | iron-sulfur cluster assembly (GO:0016226) | 2.70527588 |
| 152 | metallo-sulfur cluster assembly (GO:0031163) | 2.70527588 |
| 153 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.70519771 |
| 154 | astrocyte development (GO:0014002) | 2.70435676 |
| 155 | spinal cord development (GO:0021510) | 2.70252435 |
| 156 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 2.69611695 |
| 157 | locomotory exploration behavior (GO:0035641) | 2.69567005 |
| 158 | adult walking behavior (GO:0007628) | 2.69480476 |
| 159 | modulation by virus of host morphology or physiology (GO:0019048) | 2.68034861 |
| 160 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.67492915 |
| 161 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.67481692 |
| 162 | chaperone-mediated protein transport (GO:0072321) | 2.67214992 |
| 163 | positive regulation of amino acid transport (GO:0051957) | 2.67052211 |
| 164 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.66830324 |
| 165 | neuron cell-cell adhesion (GO:0007158) | 2.66434707 |
| 166 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.66317660 |
| 167 | protein localization to cilium (GO:0061512) | 2.66303830 |
| 168 | chondroitin sulfate catabolic process (GO:0030207) | 2.66147726 |
| 169 | negative regulation of cardiac muscle hypertrophy (GO:0010614) | 2.65792519 |
| 170 | ribonucleoprotein complex disassembly (GO:0032988) | 2.64052604 |
| 171 | creatine metabolic process (GO:0006600) | 2.63595195 |
| 172 | lysosome localization (GO:0032418) | 2.60218273 |
| 173 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.59191452 |
| 174 | negative regulation of catecholamine secretion (GO:0033604) | 2.59053263 |
| 175 | sensory perception of chemical stimulus (GO:0007606) | 2.58894309 |
| 176 | regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 2.58579840 |
| 177 | regulation of telomere maintenance via telomerase (GO:0032210) | 2.57255516 |
| 178 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.57060816 |
| 179 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230) | 2.56247836 |
| 180 | snRNA transcription (GO:0009301) | 2.55451805 |
| 181 | axon development (GO:0061564) | 2.55111398 |
| 182 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.53901190 |
| 183 | presynaptic membrane assembly (GO:0097105) | 2.50080928 |
| 184 | lateral sprouting from an epithelium (GO:0060601) | 2.49288475 |
| 185 | sensory perception of taste (GO:0050909) | 2.49103376 |
| 186 | release of cytochrome c from mitochondria (GO:0001836) | 2.48837455 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.14743983 |
| 2 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 3.17407833 |
| 3 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 3.14790335 |
| 4 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.97735220 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.91559850 |
| 6 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.86885498 |
| 7 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.68159265 |
| 8 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.52624035 |
| 9 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.51967661 |
| 10 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.40996087 |
| 11 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.36505103 |
| 12 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.36505103 |
| 13 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.25412459 |
| 14 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.25221717 |
| 15 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.15132551 |
| 16 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.14891978 |
| 17 | VDR_22108803_ChIP-Seq_LS180_Human | 2.14600737 |
| 18 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.07314536 |
| 19 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.07063524 |
| 20 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.05300279 |
| 21 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.04678594 |
| 22 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.02374063 |
| 23 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.97258361 |
| 24 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.95166463 |
| 25 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.90965940 |
| 26 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.87805755 |
| 27 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.86823337 |
| 28 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.85921012 |
| 29 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.85446469 |
| 30 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.82416006 |
| 31 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.82136468 |
| 32 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.82010843 |
| 33 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.80762945 |
| 34 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.80155160 |
| 35 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.70409182 |
| 36 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.64460392 |
| 37 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.63140939 |
| 38 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.60124387 |
| 39 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.56588393 |
| 40 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.55309587 |
| 41 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.51736065 |
| 42 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.50934994 |
| 43 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.50557920 |
| 44 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.48998274 |
| 45 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.47903183 |
| 46 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.46212606 |
| 47 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.45337123 |
| 48 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.44314081 |
| 49 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42486708 |
| 50 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.42109060 |
| 51 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.40139854 |
| 52 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.39014146 |
| 53 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.37161010 |
| 54 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.36346097 |
| 55 | * ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.34825459 |
| 56 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.33729381 |
| 57 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.33025868 |
| 58 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.32857717 |
| 59 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.30081101 |
| 60 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.29599360 |
| 61 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.28142842 |
| 62 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.27189836 |
| 63 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.26189606 |
| 64 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.23973148 |
| 65 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.23424755 |
| 66 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.22712677 |
| 67 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.22499907 |
| 68 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.21287049 |
| 69 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.19823327 |
| 70 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.14587450 |
| 71 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.14539408 |
| 72 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.13732029 |
| 73 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.12414524 |
| 74 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.11670826 |
| 75 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.08663806 |
| 76 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.08538526 |
| 77 | P300_19829295_ChIP-Seq_ESCs_Human | 1.06968783 |
| 78 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05543857 |
| 79 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.05543514 |
| 80 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.04877905 |
| 81 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.04609934 |
| 82 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.03398785 |
| 83 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.03234069 |
| 84 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.02568663 |
| 85 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.02057412 |
| 86 | * SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.01314162 |
| 87 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99829472 |
| 88 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.98132730 |
| 89 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.97204722 |
| 90 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.97168445 |
| 91 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.96435209 |
| 92 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.95559809 |
| 93 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.95195949 |
| 94 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.95195949 |
| 95 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.93592844 |
| 96 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.93582166 |
| 97 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.93107604 |
| 98 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.92773741 |
| 99 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.92283617 |
| 100 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.91952638 |
| 101 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.91611871 |
| 102 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.91545960 |
| 103 | ERA_21632823_ChIP-Seq_H3396_Human | 0.91487799 |
| 104 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.91301093 |
| 105 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.90912232 |
| 106 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.90834631 |
| 107 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.90704110 |
| 108 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.89691100 |
| 109 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.89583706 |
| 110 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.88300597 |
| 111 | NCOR_22424771_ChIP-Seq_293T_Human | 0.88078166 |
| 112 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.87251701 |
| 113 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.87216786 |
| 114 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.87200312 |
| 115 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.86905307 |
| 116 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.86313534 |
| 117 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.85932943 |
| 118 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.85576105 |
| 119 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.85467558 |
| 120 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.85278438 |
| 121 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.84461774 |
| 122 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.84060459 |
| 123 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.83874326 |
| 124 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.83493986 |
| 125 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.83189488 |
| 126 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.82838922 |
| 127 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.81678702 |
| 128 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.81467062 |
| 129 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.81128206 |
| 130 | JUN_21703547_ChIP-Seq_K562_Human | 0.81003834 |
| 131 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.80881795 |
| 132 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.79693996 |
| 133 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.79118110 |
| 134 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.78923478 |
| 135 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78510569 |
| 136 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.78483985 |
| 137 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.77858151 |
| 138 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.77704723 |
| 139 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.77704723 |
| 140 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.77654218 |
| 141 | * CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.77545383 |
| 142 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.77264021 |
| 143 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.77202920 |
| 144 | KDM2B_26808549_Chip-Seq_REH_Human | 0.77033373 |
| 145 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.76965467 |
| 146 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.76254869 |
| 147 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.76254869 |
| 148 | EWS_26573619_Chip-Seq_HEK293_Human | 0.76013858 |
| 149 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.75822713 |
| 150 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.75705925 |
| 151 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.75445081 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004270_analgesia | 3.83983331 |
| 2 | MP0008789_abnormal_olfactory_epithelium | 3.79504766 |
| 3 | MP0000920_abnormal_myelination | 3.53220990 |
| 4 | MP0003123_paternal_imprinting | 3.41906567 |
| 5 | MP0005171_absent_coat_pigmentation | 3.15420122 |
| 6 | MP0003878_abnormal_ear_physiology | 3.12999402 |
| 7 | MP0005377_hearing/vestibular/ear_phenot | 3.12999402 |
| 8 | MP0003011_delayed_dark_adaptation | 3.11586971 |
| 9 | MP0005499_abnormal_olfactory_system | 3.11505584 |
| 10 | MP0005394_taste/olfaction_phenotype | 3.11505584 |
| 11 | MP0001485_abnormal_pinna_reflex | 3.05366345 |
| 12 | MP0001188_hyperpigmentation | 2.99208525 |
| 13 | MP0005645_abnormal_hypothalamus_physiol | 2.97768748 |
| 14 | MP0002653_abnormal_ependyma_morphology | 2.95681314 |
| 15 | MP0002822_catalepsy | 2.85865721 |
| 16 | MP0003122_maternal_imprinting | 2.73083450 |
| 17 | MP0003806_abnormal_nucleotide_metabolis | 2.68030288 |
| 18 | MP0003121_genomic_imprinting | 2.46148602 |
| 19 | MP0002163_abnormal_gland_morphology | 2.29799554 |
| 20 | MP0008438_abnormal_cutaneous_collagen | 2.28668388 |
| 21 | MP0003950_abnormal_plasma_membrane | 2.25135066 |
| 22 | MP0001984_abnormal_olfaction | 2.22513191 |
| 23 | MP0000778_abnormal_nervous_system | 2.19075595 |
| 24 | MP0004134_abnormal_chest_morphology | 2.15557057 |
| 25 | MP0005623_abnormal_meninges_morphology | 2.15434542 |
| 26 | MP0000372_irregular_coat_pigmentation | 2.11262901 |
| 27 | MP0000003_abnormal_adipose_tissue | 2.09963452 |
| 28 | MP0008877_abnormal_DNA_methylation | 2.07568249 |
| 29 | MP0003880_abnormal_central_pattern | 2.01625865 |
| 30 | MP0001486_abnormal_startle_reflex | 2.00337979 |
| 31 | MP0001905_abnormal_dopamine_level | 2.00221088 |
| 32 | MP0002909_abnormal_adrenal_gland | 1.93620736 |
| 33 | MP0004858_abnormal_nervous_system | 1.92412750 |
| 34 | MP0004145_abnormal_muscle_electrophysio | 1.90055227 |
| 35 | MP0001968_abnormal_touch/_nociception | 1.87103530 |
| 36 | MP0002272_abnormal_nervous_system | 1.86708474 |
| 37 | MP0003136_yellow_coat_color | 1.86441661 |
| 38 | MP0004742_abnormal_vestibular_system | 1.81618083 |
| 39 | MP0001542_abnormal_bone_strength | 1.79321492 |
| 40 | MP0002638_abnormal_pupillary_reflex | 1.78106223 |
| 41 | MP0004885_abnormal_endolymph | 1.77300710 |
| 42 | MP0005083_abnormal_biliary_tract | 1.73583428 |
| 43 | MP0005464_abnormal_platelet_physiology | 1.73248126 |
| 44 | MP0002733_abnormal_thermal_nociception | 1.66179074 |
| 45 | MP0000015_abnormal_ear_pigmentation | 1.58443345 |
| 46 | MP0003634_abnormal_glial_cell | 1.57822071 |
| 47 | MP0002736_abnormal_nociception_after | 1.55654672 |
| 48 | MP0006276_abnormal_autonomic_nervous | 1.55233550 |
| 49 | MP0002160_abnormal_reproductive_system | 1.54496911 |
| 50 | MP0002938_white_spotting | 1.50050111 |
| 51 | MP0005423_abnormal_somatic_nervous | 1.49604503 |
| 52 | MP0004811_abnormal_neuron_physiology | 1.48579719 |
| 53 | MP0003879_abnormal_hair_cell | 1.48388044 |
| 54 | MP0005410_abnormal_fertilization | 1.46849409 |
| 55 | MP0002734_abnormal_mechanical_nocicepti | 1.45627264 |
| 56 | MP0002229_neurodegeneration | 1.45082360 |
| 57 | MP0001963_abnormal_hearing_physiology | 1.44372065 |
| 58 | MP0005167_abnormal_blood-brain_barrier | 1.44106289 |
| 59 | MP0003690_abnormal_glial_cell | 1.43567038 |
| 60 | MP0009379_abnormal_foot_pigmentation | 1.43052468 |
| 61 | MP0002295_abnormal_pulmonary_circulatio | 1.41370871 |
| 62 | MP0001919_abnormal_reproductive_system | 1.40806857 |
| 63 | MP0004381_abnormal_hair_follicle | 1.38470440 |
| 64 | MP0005379_endocrine/exocrine_gland_phen | 1.37070793 |
| 65 | MP0001529_abnormal_vocalization | 1.36421849 |
| 66 | MP0002064_seizures | 1.36138066 |
| 67 | MP0003890_abnormal_embryonic-extraembry | 1.34535453 |
| 68 | MP0002882_abnormal_neuron_morphology | 1.33959672 |
| 69 | MP0002752_abnormal_somatic_nervous | 1.32396946 |
| 70 | MP0005084_abnormal_gallbladder_morpholo | 1.29213805 |
| 71 | MP0010386_abnormal_urinary_bladder | 1.29063472 |
| 72 | MP0002928_abnormal_bile_duct | 1.28524322 |
| 73 | MP0000026_abnormal_inner_ear | 1.28442876 |
| 74 | MP0002184_abnormal_innervation | 1.27929967 |
| 75 | MP0001348_abnormal_lacrimal_gland | 1.27818355 |
| 76 | MP0005389_reproductive_system_phenotype | 1.27002073 |
| 77 | MP0004859_abnormal_synaptic_plasticity | 1.26851227 |
| 78 | MP0000647_abnormal_sebaceous_gland | 1.24595213 |
| 79 | MP0005503_abnormal_tendon_morphology | 1.21724142 |
| 80 | MP0006292_abnormal_olfactory_placode | 1.18917692 |
| 81 | MP0000762_abnormal_tongue_morphology | 1.18352306 |
| 82 | MP0003632_abnormal_nervous_system | 1.16849844 |
| 83 | MP0003635_abnormal_synaptic_transmissio | 1.14737004 |
| 84 | MP0002233_abnormal_nose_morphology | 1.13399924 |
| 85 | MP0004142_abnormal_muscle_tone | 1.12670839 |
| 86 | MP0001440_abnormal_grooming_behavior | 1.12374641 |
| 87 | MP0010678_abnormal_skin_adnexa | 1.11754189 |
| 88 | MP0001346_abnormal_lacrimal_gland | 1.11238598 |
| 89 | MP0003938_abnormal_ear_development | 1.11230493 |
| 90 | MP0004130_abnormal_muscle_cell | 1.09670257 |
| 91 | MP0006072_abnormal_retinal_apoptosis | 1.08399453 |
| 92 | MP0003866_abnormal_defecation | 1.07324095 |
| 93 | MP0000383_abnormal_hair_follicle | 1.07298536 |
| 94 | MP0003631_nervous_system_phenotype | 1.06924585 |
| 95 | MP0005451_abnormal_body_composition | 1.05578656 |
| 96 | MP0009250_abnormal_appendicular_skeleto | 1.02605156 |
| 97 | MP0005253_abnormal_eye_physiology | 0.99143201 |
| 98 | MP0005671_abnormal_response_to | 0.99090325 |
| 99 | MP0000230_abnormal_systemic_arterial | 0.98920993 |
| 100 | MP0002102_abnormal_ear_morphology | 0.96961481 |
| 101 | MP0000955_abnormal_spinal_cord | 0.96602946 |
| 102 | MP0003329_amyloid_beta_deposits | 0.96543801 |
| 103 | MP0005275_abnormal_skin_tensile | 0.95785373 |
| 104 | MP0000467_abnormal_esophagus_morphology | 0.95358144 |
| 105 | MP0002572_abnormal_emotion/affect_behav | 0.94864780 |
| 106 | MP0004133_heterotaxia | 0.94721605 |
| 107 | MP0002751_abnormal_autonomic_nervous | 0.94539221 |
| 108 | MP0002152_abnormal_brain_morphology | 0.94155670 |
| 109 | MP0004924_abnormal_behavior | 0.93139677 |
| 110 | MP0005386_behavior/neurological_phenoty | 0.93139677 |
| 111 | MP0005551_abnormal_eye_electrophysiolog | 0.91658368 |
| 112 | MP0005408_hypopigmentation | 0.91574623 |
| 113 | MP0003937_abnormal_limbs/digits/tail_de | 0.91218579 |
| 114 | MP0001970_abnormal_pain_threshold | 0.90868911 |
| 115 | MP0005195_abnormal_posterior_eye | 0.90668892 |
| 116 | MP0009745_abnormal_behavioral_response | 0.88963227 |
| 117 | MP0003942_abnormal_urinary_system | 0.88469841 |
| 118 | MP0009046_muscle_twitch | 0.87060998 |
| 119 | MP0002063_abnormal_learning/memory/cond | 0.86750265 |
| 120 | MP0003656_abnormal_erythrocyte_physiolo | 0.86361535 |
| 121 | MP0008004_abnormal_stomach_pH | 0.86058191 |
| 122 | MP0002735_abnormal_chemical_nociception | 0.85015153 |
| 123 | MP0000631_abnormal_neuroendocrine_gland | 0.84325240 |
| 124 | MP0003861_abnormal_nervous_system | 0.84277443 |
| 125 | MP0001958_emphysema | 0.82721548 |
| 126 | MP0001727_abnormal_embryo_implantation | 0.81907766 |
| 127 | MP0002066_abnormal_motor_capabilities/c | 0.80779237 |
| 128 | MP0002557_abnormal_social/conspecific_i | 0.80394287 |
| 129 | MP0003646_muscle_fatigue | 0.80214311 |
| 130 | MP0008872_abnormal_physiological_respon | 0.79049680 |
| 131 | MP0002249_abnormal_larynx_morphology | 0.77317100 |
| 132 | MP0002067_abnormal_sensory_capabilities | 0.77136760 |
| 133 | MP0005409_darkened_coat_color | 0.76885724 |
| 134 | MP0005646_abnormal_pituitary_gland | 0.75402113 |
| 135 | MP0000566_synostosis | 0.74739039 |
| 136 | MP0005375_adipose_tissue_phenotype | 0.74126360 |
| 137 | MP0008569_lethality_at_weaning | 0.73917493 |
| 138 | MP0001340_abnormal_eyelid_morphology | 0.71042041 |
| 139 | MP0003137_abnormal_impulse_conducting | 0.69736058 |
| 140 | MP0003638_abnormal_response/metabolism_ | 0.64987381 |
| 141 | MP0001177_atelectasis | 0.64364534 |
| 142 | MP0004147_increased_porphyrin_level | 0.64124076 |
| 143 | MP0004043_abnormal_pH_regulation | 0.63174936 |
| 144 | MP0000462_abnormal_digestive_system | 0.63119601 |
| 145 | MP0001293_anophthalmia | 0.62292337 |
| 146 | MP0002069_abnormal_eating/drinking_beha | 0.61501643 |
| 147 | MP0003633_abnormal_nervous_system | 0.60745758 |
| 148 | MP0003787_abnormal_imprinting | 0.59851848 |
| 149 | MP0005187_abnormal_penis_morphology | 0.59496359 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 5.56885717 |
| 2 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 5.56885717 |
| 3 | Retinal dysplasia (HP:0007973) | 4.95013473 |
| 4 | Neurofibrillary tangles (HP:0002185) | 4.34584327 |
| 5 | Papilledema (HP:0001085) | 4.27453714 |
| 6 | Parakeratosis (HP:0001036) | 4.24255810 |
| 7 | Abnormality of the corticospinal tract (HP:0002492) | 4.10505949 |
| 8 | Agitation (HP:0000713) | 3.91320496 |
| 9 | Abnormal pancreas size (HP:0012094) | 3.59720825 |
| 10 | Progressive cerebellar ataxia (HP:0002073) | 3.51291698 |
| 11 | Polyphagia (HP:0002591) | 3.50771696 |
| 12 | Anomalous pulmonary venous return (HP:0010772) | 3.32216877 |
| 13 | Methylmalonic acidemia (HP:0002912) | 3.26142407 |
| 14 | Cerebral inclusion bodies (HP:0100314) | 3.14483398 |
| 15 | Diastasis recti (HP:0001540) | 3.06064652 |
| 16 | Anosmia (HP:0000458) | 3.05526402 |
| 17 | Ankle clonus (HP:0011448) | 3.01636360 |
| 18 | Peripheral hypomyelination (HP:0007182) | 2.98845745 |
| 19 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.98735727 |
| 20 | Hypoplasia of the iris (HP:0007676) | 2.97701113 |
| 21 | Drooling (HP:0002307) | 2.96161481 |
| 22 | Hyperthyroidism (HP:0000836) | 2.95062440 |
| 23 | Onion bulb formation (HP:0003383) | 2.94061563 |
| 24 | Hepatoblastoma (HP:0002884) | 2.92054654 |
| 25 | Nephronophthisis (HP:0000090) | 2.88810988 |
| 26 | Supranuclear gaze palsy (HP:0000605) | 2.86851468 |
| 27 | Abnormal ciliary motility (HP:0012262) | 2.82284044 |
| 28 | Abnormality of the pulmonary veins (HP:0011718) | 2.81801874 |
| 29 | Hypothermia (HP:0002045) | 2.80139666 |
| 30 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.77768617 |
| 31 | Excessive salivation (HP:0003781) | 2.75882285 |
| 32 | Thyroid-stimulating hormone excess (HP:0002925) | 2.71367756 |
| 33 | Limb dystonia (HP:0002451) | 2.70844175 |
| 34 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.68469492 |
| 35 | Hypoplasia of the brainstem (HP:0002365) | 2.68469492 |
| 36 | Abnormality of midbrain morphology (HP:0002418) | 2.67848663 |
| 37 | Molar tooth sign on MRI (HP:0002419) | 2.67848663 |
| 38 | Spastic gait (HP:0002064) | 2.64855643 |
| 39 | Foot dorsiflexor weakness (HP:0009027) | 2.64565949 |
| 40 | Termporal pattern (HP:0011008) | 2.64176545 |
| 41 | Insidious onset (HP:0003587) | 2.64176545 |
| 42 | Pachygyria (HP:0001302) | 2.63979616 |
| 43 | Autoamputation (HP:0001218) | 2.60743484 |
| 44 | Neoplasm of the adrenal cortex (HP:0100641) | 2.59830003 |
| 45 | Myokymia (HP:0002411) | 2.58835611 |
| 46 | Scanning speech (HP:0002168) | 2.57823964 |
| 47 | Sensory axonal neuropathy (HP:0003390) | 2.57291960 |
| 48 | Rhinitis (HP:0012384) | 2.55350424 |
| 49 | Alacrima (HP:0000522) | 2.54592301 |
| 50 | Abnormality of dentin (HP:0010299) | 2.54232451 |
| 51 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.54195177 |
| 52 | Septate vagina (HP:0001153) | 2.53707721 |
| 53 | Metaphyseal dysplasia (HP:0100255) | 2.53456746 |
| 54 | White forelock (HP:0002211) | 2.52170037 |
| 55 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.51799754 |
| 56 | Rib fusion (HP:0000902) | 2.51434832 |
| 57 | Stridor (HP:0010307) | 2.50873322 |
| 58 | Patchy hypopigmentation of hair (HP:0011365) | 2.48826509 |
| 59 | Poor suck (HP:0002033) | 2.48722942 |
| 60 | Spastic tetraplegia (HP:0002510) | 2.48486283 |
| 61 | Inability to walk (HP:0002540) | 2.48412217 |
| 62 | Febrile seizures (HP:0002373) | 2.45665968 |
| 63 | Failure to thrive in infancy (HP:0001531) | 2.41851293 |
| 64 | Infantile muscular hypotonia (HP:0008947) | 2.41775075 |
| 65 | Visual hallucinations (HP:0002367) | 2.40269282 |
| 66 | Xerostomia (HP:0000217) | 2.38923197 |
| 67 | Vaginal atresia (HP:0000148) | 2.36773437 |
| 68 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.36584306 |
| 69 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.35314044 |
| 70 | Abnormality of the foot musculature (HP:0001436) | 2.35034304 |
| 71 | Cortical dysplasia (HP:0002539) | 2.33916226 |
| 72 | Medial flaring of the eyebrow (HP:0010747) | 2.33789776 |
| 73 | Acute necrotizing encephalopathy (HP:0006965) | 2.32922948 |
| 74 | Split foot (HP:0001839) | 2.32782743 |
| 75 | Genital tract atresia (HP:0001827) | 2.32778827 |
| 76 | Lissencephaly (HP:0001339) | 2.30388177 |
| 77 | Neonatal hypoglycemia (HP:0001998) | 2.29258458 |
| 78 | Aplasia/Hypoplasia of the lens (HP:0008063) | 2.29034601 |
| 79 | Abnormality of the renal medulla (HP:0100957) | 2.28615683 |
| 80 | Hammertoe (HP:0001765) | 2.25905947 |
| 81 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.23465254 |
| 82 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.23465254 |
| 83 | Hypoplastic left heart (HP:0004383) | 2.22024562 |
| 84 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.21918397 |
| 85 | Fetal akinesia sequence (HP:0001989) | 2.21657350 |
| 86 | Hypoplastic pelvis (HP:0008839) | 2.20957958 |
| 87 | Gait imbalance (HP:0002141) | 2.20709401 |
| 88 | 3-Methylglutaconic aciduria (HP:0003535) | 2.19705146 |
| 89 | Thickened helices (HP:0000391) | 2.19541718 |
| 90 | Abnormal auditory evoked potentials (HP:0006958) | 2.18586645 |
| 91 | Absent eyebrow (HP:0002223) | 2.16484137 |
| 92 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.13318869 |
| 93 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.12673883 |
| 94 | Amblyopia (HP:0000646) | 2.11491809 |
| 95 | Tubular atrophy (HP:0000092) | 2.10113259 |
| 96 | Premature rupture of membranes (HP:0001788) | 2.08069327 |
| 97 | Increased IgM level (HP:0003496) | 2.07982892 |
| 98 | Focal seizures (HP:0007359) | 2.07958776 |
| 99 | Submucous cleft hard palate (HP:0000176) | 2.06670662 |
| 100 | Petechiae (HP:0000967) | 2.05519662 |
| 101 | Myelomeningocele (HP:0002475) | 2.04934704 |
| 102 | Metabolic alkalosis (HP:0200114) | 2.04548091 |
| 103 | Growth hormone deficiency (HP:0000824) | 2.03821847 |
| 104 | Aplasia involving bones of the extremities (HP:0009825) | 2.03637829 |
| 105 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.03637829 |
| 106 | Aplasia of the phalanges of the hand (HP:0009802) | 2.03637829 |
| 107 | Polymicrogyria (HP:0002126) | 2.02949283 |
| 108 | Premature skin wrinkling (HP:0100678) | 2.02695836 |
| 109 | Cerebral hypomyelination (HP:0006808) | 2.02280028 |
| 110 | Acute encephalopathy (HP:0006846) | 2.01863491 |
| 111 | Leukodystrophy (HP:0002415) | 2.01037176 |
| 112 | Chronic bronchitis (HP:0004469) | 1.99856874 |
| 113 | Amyloidosis (HP:0011034) | 1.99596175 |
| 114 | Adrenal hypoplasia (HP:0000835) | 1.98462941 |
| 115 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.98407807 |
| 116 | Lower limb muscle weakness (HP:0007340) | 1.98116810 |
| 117 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.97528624 |
| 118 | Congenital primary aphakia (HP:0007707) | 1.97027921 |
| 119 | Bell-shaped thorax (HP:0001591) | 1.96294988 |
| 120 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.95590933 |
| 121 | Wormian bones (HP:0002645) | 1.95312869 |
| 122 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.93365934 |
| 123 | Muscle fiber splitting (HP:0003555) | 1.92781192 |
| 124 | Purpura (HP:0000979) | 1.91726379 |
| 125 | Disproportionate tall stature (HP:0001519) | 1.89221964 |
| 126 | Bilateral microphthalmos (HP:0007633) | 1.89185613 |
| 127 | Dysmetria (HP:0001310) | 1.89097598 |
| 128 | Mitochondrial inheritance (HP:0001427) | 1.88261945 |
| 129 | Abnormality of the intervertebral disk (HP:0005108) | 1.88245985 |
| 130 | Clumsiness (HP:0002312) | 1.87867661 |
| 131 | Type 2 muscle fiber atrophy (HP:0003554) | 1.86957955 |
| 132 | Intention tremor (HP:0002080) | 1.86908013 |
| 133 | Spastic tetraparesis (HP:0001285) | 1.86889317 |
| 134 | Abnormal hair whorl (HP:0010721) | 1.86359106 |
| 135 | Narrow forehead (HP:0000341) | 1.86241683 |
| 136 | Renal Fanconi syndrome (HP:0001994) | 1.86193035 |
| 137 | Morphological abnormality of the middle ear (HP:0008609) | 1.85116727 |
| 138 | Prolonged bleeding time (HP:0003010) | 1.84786611 |
| 139 | Enlarged kidneys (HP:0000105) | 1.83194062 |
| 140 | Amyotrophic lateral sclerosis (HP:0007354) | 1.82404848 |
| 141 | Bicornuate uterus (HP:0000813) | 1.81792318 |
| 142 | Abnormal eating behavior (HP:0100738) | 1.81527727 |
| 143 | Anophthalmia (HP:0000528) | 1.81278384 |
| 144 | Broad metatarsal (HP:0001783) | 1.80550514 |
| 145 | Absent septum pellucidum (HP:0001331) | 1.80439453 |
| 146 | Decreased lacrimation (HP:0000633) | 1.80378960 |
| 147 | Nephrogenic diabetes insipidus (HP:0009806) | 1.80168836 |
| 148 | Abnormality of the septum pellucidum (HP:0007375) | 1.80022018 |
| 149 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.79796001 |
| 150 | Absent/shortened dynein arms (HP:0200106) | 1.79796001 |
| 151 | Coronal craniosynostosis (HP:0004440) | 1.79341546 |
| 152 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.79238287 |
| 153 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.79083888 |
| 154 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.78765829 |
| 155 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.78765829 |
| 156 | Bradycardia (HP:0001662) | 1.78294534 |
| 157 | Progressive macrocephaly (HP:0004481) | 1.77036529 |
| 158 | Abnormality of molar morphology (HP:0011070) | 1.77031659 |
| 159 | Abnormality of molar (HP:0011077) | 1.77031659 |
| 160 | Optic disc pallor (HP:0000543) | 1.76762504 |
| 161 | Sclerocornea (HP:0000647) | 1.76347197 |
| 162 | Narrow nasal bridge (HP:0000446) | 1.76110955 |
| 163 | Megalencephaly (HP:0001355) | 1.75598342 |
| 164 | Methylmalonic aciduria (HP:0012120) | 1.74681960 |
| 165 | Axonal loss (HP:0003447) | 1.74613220 |
| 166 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.74204272 |
| 167 | Bronchiectasis (HP:0002110) | 1.74008025 |
| 168 | Hypoplastic heart (HP:0001961) | 1.71379043 |
| 169 | Synostosis involving the elbow (HP:0003938) | 1.70558722 |
| 170 | Humeroradial synostosis (HP:0003041) | 1.70558722 |
| 171 | Congenital sensorineural hearing impairment (HP:0008527) | 1.70250848 |
| 172 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.69866707 |
| 173 | Optic nerve coloboma (HP:0000588) | 1.69644011 |
| 174 | Decreased motor nerve conduction velocity (HP:0003431) | 1.68623521 |
| 175 | Slow saccadic eye movements (HP:0000514) | 1.67961541 |
| 176 | Restlessness (HP:0000711) | 1.67643885 |
| 177 | Menstrual irregularities (HP:0000858) | 1.66966161 |
| 178 | Focal motor seizures (HP:0011153) | 1.66601501 |
| 179 | Chronic sinusitis (HP:0011109) | 1.64481336 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ARAF | 5.42037373 |
| 2 | RIPK1 | 4.62719740 |
| 3 | STK39 | 4.40458503 |
| 4 | OXSR1 | 2.77104694 |
| 5 | PIM2 | 2.71923797 |
| 6 | MAP3K4 | 2.66906927 |
| 7 | MAPKAPK5 | 2.47131363 |
| 8 | CAMKK2 | 2.43700828 |
| 9 | BMPR2 | 2.36701463 |
| 10 | BRAF | 2.35442092 |
| 11 | IRAK2 | 2.35247601 |
| 12 | TXK | 2.34028790 |
| 13 | PRPF4B | 2.33735090 |
| 14 | ERBB3 | 2.22614136 |
| 15 | PINK1 | 2.21191734 |
| 16 | NUAK1 | 2.11407389 |
| 17 | EPHB2 | 2.02323612 |
| 18 | MAP4K2 | 2.00965560 |
| 19 | BCR | 1.83766001 |
| 20 | PKN1 | 1.83645632 |
| 21 | CSNK1A1L | 1.80958546 |
| 22 | CSNK1G3 | 1.79811899 |
| 23 | ADRBK2 | 1.79727105 |
| 24 | MAPK15 | 1.76499360 |
| 25 | EPHB1 | 1.74146655 |
| 26 | WNK3 | 1.73420308 |
| 27 | DDR2 | 1.70902046 |
| 28 | UHMK1 | 1.64441645 |
| 29 | NTRK3 | 1.63812032 |
| 30 | WNK4 | 1.57253683 |
| 31 | LIMK1 | 1.57167811 |
| 32 | MAP2K4 | 1.54743694 |
| 33 | CAMKK1 | 1.53249988 |
| 34 | DMPK | 1.51146091 |
| 35 | FGR | 1.49805593 |
| 36 | BMPR1B | 1.49190992 |
| 37 | PRKCG | 1.46498392 |
| 38 | DYRK3 | 1.45469355 |
| 39 | CAMK2B | 1.45410238 |
| 40 | FGFR2 | 1.45133660 |
| 41 | CSNK1G2 | 1.42679857 |
| 42 | EPHA3 | 1.37591058 |
| 43 | CSNK1G1 | 1.36223068 |
| 44 | CASK | 1.35998968 |
| 45 | ICK | 1.31919395 |
| 46 | SGK3 | 1.31793525 |
| 47 | MET | 1.31660462 |
| 48 | SGK223 | 1.29883433 |
| 49 | SGK494 | 1.29883433 |
| 50 | DYRK2 | 1.28171011 |
| 51 | CAMK1G | 1.24731165 |
| 52 | MAPK13 | 1.23708413 |
| 53 | TESK2 | 1.21470829 |
| 54 | RAF1 | 1.21124573 |
| 55 | WNK1 | 1.18904206 |
| 56 | CAMK2G | 1.16590728 |
| 57 | CAMK2D | 1.12952642 |
| 58 | CAMK1 | 1.12625005 |
| 59 | SIK2 | 1.09230912 |
| 60 | CAMK1D | 1.07297137 |
| 61 | MARK1 | 1.03665451 |
| 62 | MAP2K7 | 0.99568653 |
| 63 | CDK19 | 0.94575757 |
| 64 | ROCK2 | 0.94483307 |
| 65 | GRK7 | 0.93931090 |
| 66 | BTK | 0.93286291 |
| 67 | NTRK1 | 0.90124103 |
| 68 | ERBB2 | 0.90062865 |
| 69 | PIK3CA | 0.89713986 |
| 70 | PLK2 | 0.89666198 |
| 71 | ILK | 0.89484967 |
| 72 | TLK1 | 0.89317322 |
| 73 | BCKDK | 0.87846165 |
| 74 | TRIM28 | 0.86430104 |
| 75 | PNCK | 0.85182464 |
| 76 | DYRK1A | 0.84682234 |
| 77 | PRKCE | 0.83407269 |
| 78 | PBK | 0.83369393 |
| 79 | NTRK2 | 0.82395132 |
| 80 | PRKD1 | 0.80183798 |
| 81 | ADRBK1 | 0.77342637 |
| 82 | TYRO3 | 0.73598852 |
| 83 | RPS6KA5 | 0.72665348 |
| 84 | PRKCQ | 0.72131433 |
| 85 | MKNK1 | 0.72104391 |
| 86 | SYK | 0.69811207 |
| 87 | TRPM7 | 0.69492910 |
| 88 | GSK3A | 0.68738025 |
| 89 | MARK2 | 0.67586874 |
| 90 | MAP3K6 | 0.66330863 |
| 91 | PHKG2 | 0.66274739 |
| 92 | PHKG1 | 0.66274739 |
| 93 | SIK3 | 0.66048662 |
| 94 | PRKACA | 0.64747988 |
| 95 | AKT3 | 0.63020275 |
| 96 | PLK3 | 0.62988703 |
| 97 | EPHA4 | 0.60722735 |
| 98 | STK11 | 0.59634096 |
| 99 | CDK14 | 0.58786919 |
| 100 | PRKCD | 0.58161948 |
| 101 | PAK3 | 0.57491445 |
| 102 | HIPK2 | 0.57361972 |
| 103 | NEK6 | 0.55185435 |
| 104 | PRKCH | 0.54745623 |
| 105 | MAPKAPK2 | 0.54029954 |
| 106 | CAMK2A | 0.53888385 |
| 107 | MINK1 | 0.53168809 |
| 108 | DAPK2 | 0.53153304 |
| 109 | CDK15 | 0.53129832 |
| 110 | GRK5 | 0.52558224 |
| 111 | CAMK4 | 0.51753041 |
| 112 | CDK18 | 0.51372278 |
| 113 | PRKACG | 0.51326704 |
| 114 | SGK2 | 0.51306473 |
| 115 | RIPK4 | 0.51216295 |
| 116 | TNIK | 0.50439846 |
| 117 | ITK | 0.50352844 |
| 118 | STK16 | 0.50110161 |
| 119 | PRKG1 | 0.48667387 |
| 120 | CDK5 | 0.48069230 |
| 121 | MAP2K2 | 0.47801798 |
| 122 | PRKD3 | 0.47471142 |
| 123 | ERBB4 | 0.45883094 |
| 124 | MST4 | 0.45528134 |
| 125 | CDK11A | 0.45181003 |
| 126 | CLK1 | 0.45131229 |
| 127 | TAOK3 | 0.43296625 |
| 128 | LCK | 0.42524846 |
| 129 | PRKAA1 | 0.42014954 |
| 130 | PRKCZ | 0.41987054 |
| 131 | MAPK4 | 0.40582859 |
| 132 | SGK1 | 0.39620290 |
| 133 | FYN | 0.36333095 |
| 134 | ROCK1 | 0.35764128 |
| 135 | RPS6KA2 | 0.32985122 |
| 136 | PAK1 | 0.32108695 |
| 137 | MAP3K13 | 0.30470226 |
| 138 | PAK6 | 0.30264026 |
| 139 | PTK2B | 0.30138191 |
| 140 | MAP3K11 | 0.29827365 |
| 141 | PRKD2 | 0.29602562 |
| 142 | GRK1 | 0.28685485 |
| 143 | MATK | 0.27887231 |
| 144 | MAPK9 | 0.27194182 |
| 145 | PRKCI | 0.26920920 |
| 146 | AURKA | 0.26026735 |
| 147 | DYRK1B | 0.24624883 |
| 148 | PRKACB | 0.24261253 |
| 149 | TAOK1 | 0.24204196 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 4.95179730 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 4.15861781 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.79025233 |
| 4 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.03428023 |
| 5 | Olfactory transduction_Homo sapiens_hsa04740 | 2.82756649 |
| 6 | Nicotine addiction_Homo sapiens_hsa05033 | 2.65813236 |
| 7 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.55578298 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.53351503 |
| 9 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.19263964 |
| 10 | Phototransduction_Homo sapiens_hsa04744 | 2.15343780 |
| 11 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.02414913 |
| 12 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.85951625 |
| 13 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.82584205 |
| 14 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.81480909 |
| 15 | Histidine metabolism_Homo sapiens_hsa00340 | 1.76562292 |
| 16 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.72807972 |
| 17 | * Serotonergic synapse_Homo sapiens_hsa04726 | 1.70993744 |
| 18 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.70232912 |
| 19 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.69344091 |
| 20 | Tight junction_Homo sapiens_hsa04530 | 1.60790986 |
| 21 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.57440711 |
| 22 | Protein export_Homo sapiens_hsa03060 | 1.56506372 |
| 23 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.53611303 |
| 24 | Axon guidance_Homo sapiens_hsa04360 | 1.52941223 |
| 25 | * GABAergic synapse_Homo sapiens_hsa04727 | 1.49746965 |
| 26 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.48487595 |
| 27 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.45374831 |
| 28 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.43062987 |
| 29 | * Glutamatergic synapse_Homo sapiens_hsa04724 | 1.39336262 |
| 30 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.38790578 |
| 31 | * Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.35313711 |
| 32 | Alzheimers disease_Homo sapiens_hsa05010 | 1.32523451 |
| 33 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.32159454 |
| 34 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.31650080 |
| 35 | * Morphine addiction_Homo sapiens_hsa05032 | 1.31432504 |
| 36 | * Circadian entrainment_Homo sapiens_hsa04713 | 1.24065100 |
| 37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.23647239 |
| 38 | Taste transduction_Homo sapiens_hsa04742 | 1.23436570 |
| 39 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.20431629 |
| 40 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.18945995 |
| 41 | Parkinsons disease_Homo sapiens_hsa05012 | 1.16935368 |
| 42 | * Cholinergic synapse_Homo sapiens_hsa04725 | 1.10608603 |
| 43 | * Ras signaling pathway_Homo sapiens_hsa04014 | 1.08060343 |
| 44 | Insulin secretion_Homo sapiens_hsa04911 | 1.06478325 |
| 45 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.05590944 |
| 46 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.05439148 |
| 47 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.02172277 |
| 48 | * Dopaminergic synapse_Homo sapiens_hsa04728 | 0.98868572 |
| 49 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.96600442 |
| 50 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.96166308 |
| 51 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.96127651 |
| 52 | Long-term depression_Homo sapiens_hsa04730 | 0.95418392 |
| 53 | Salmonella infection_Homo sapiens_hsa05132 | 0.93266441 |
| 54 | Huntingtons disease_Homo sapiens_hsa05016 | 0.91085486 |
| 55 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.89287327 |
| 56 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.86910931 |
| 57 | Platelet activation_Homo sapiens_hsa04611 | 0.85115622 |
| 58 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.84344425 |
| 59 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.78734674 |
| 60 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.78537739 |
| 61 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.75946917 |
| 62 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.75411393 |
| 63 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.75389224 |
| 64 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.75221953 |
| 65 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.74339181 |
| 66 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.74102818 |
| 67 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.72618689 |
| 68 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.72215140 |
| 69 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.71729135 |
| 70 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.71462769 |
| 71 | Hepatitis C_Homo sapiens_hsa05160 | 0.71245374 |
| 72 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.70768187 |
| 73 | Asthma_Homo sapiens_hsa05310 | 0.70562326 |
| 74 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.70090918 |
| 75 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.68309336 |
| 76 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.67454000 |
| 77 | Prion diseases_Homo sapiens_hsa05020 | 0.65751592 |
| 78 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.65725824 |
| 79 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.65298489 |
| 80 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.63388113 |
| 81 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.62981815 |
| 82 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.62958985 |
| 83 | RNA polymerase_Homo sapiens_hsa03020 | 0.62592535 |
| 84 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.62583007 |
| 85 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.62331359 |
| 86 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.61953452 |
| 87 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.60900070 |
| 88 | * Alcoholism_Homo sapiens_hsa05034 | 0.59978032 |
| 89 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.59626931 |
| 90 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59599091 |
| 91 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.58327459 |
| 92 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.56820535 |
| 93 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.54741617 |
| 94 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.53034240 |
| 95 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.52600094 |
| 96 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.52450771 |
| 97 | Gap junction_Homo sapiens_hsa04540 | 0.52327741 |
| 98 | Mineral absorption_Homo sapiens_hsa04978 | 0.51936690 |
| 99 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.51807694 |
| 100 | Phagosome_Homo sapiens_hsa04145 | 0.50807359 |
| 101 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.50079648 |
| 102 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.49965713 |
| 103 | Cocaine addiction_Homo sapiens_hsa05030 | 0.49711912 |
| 104 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.48851319 |
| 105 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.48594095 |
| 106 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.48531542 |
| 107 | * PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.48404985 |
| 108 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.47658928 |
| 109 | Peroxisome_Homo sapiens_hsa04146 | 0.47168500 |
| 110 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.46062145 |
| 111 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.45701782 |
| 112 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.45545655 |
| 113 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.45071370 |
| 114 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.44995036 |
| 115 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.44061051 |
| 116 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.43846316 |
| 117 | Ribosome_Homo sapiens_hsa03010 | 0.43222178 |
| 118 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.41819176 |
| 119 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.41186227 |
| 120 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.41069686 |
| 121 | Allograft rejection_Homo sapiens_hsa05330 | 0.40216305 |
| 122 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.39972087 |
| 123 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.38851285 |
| 124 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.38684839 |
| 125 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.38206004 |
| 126 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.37572939 |
| 127 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.36917096 |
| 128 | Melanogenesis_Homo sapiens_hsa04916 | 0.35504378 |
| 129 | Renin secretion_Homo sapiens_hsa04924 | 0.35434089 |
| 130 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.33994440 |
| 131 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.33560207 |
| 132 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.33491201 |
| 133 | Melanoma_Homo sapiens_hsa05218 | 0.32180862 |
| 134 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.31988327 |
| 135 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.30129517 |
| 136 | Endocytosis_Homo sapiens_hsa04144 | 0.30068608 |
| 137 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.29814717 |
| 138 | Salivary secretion_Homo sapiens_hsa04970 | 0.29628745 |
| 139 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.29447123 |
| 140 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.27457264 |
| 141 | Endometrial cancer_Homo sapiens_hsa05213 | 0.26897485 |

